Dr. Bareia Chaudhry, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,008 | 41 | 98.5% |
| Education | $15.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $124.99 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $101.02 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $92.96 | 4 | $0 (2024) |
| Lilly USA, LLC | $92.11 | 4 | $0 (2024) |
| Incyte Corporation | $77.42 | 3 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $75.67 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $72.19 | 3 | $0 (2024) |
| PFIZER INC. | $50.89 | 3 | $0 (2024) |
| Amgen Inc. | $44.66 | 2 | $0 (2023) |
| Daiichi Sankyo Inc. | $29.98 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.36 | 28 | Janssen Biotech, Inc. ($101.02) |
| 2023 | $406.99 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($124.99) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 08/21/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/30/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/26/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.85 | General |
| 06/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Oncology | ||||||
| 05/30/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: HEMATOLOGY | ||||||
| 05/21/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 05/03/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $28.79 | General |
| Category: Oncology | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Oncology | ||||||
| 03/07/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Oncology | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: Oncology | ||||||
| 02/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: ONCOLOGY | ||||||
| 02/02/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 01/31/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 3,012 | 15,691 | $571,934 | $247,130 |
| 2022 | 31 | 1,403 | 4,120 | $144,808 | $65,976 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 25 | 33 | $115,500 | $42,581 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 392 | $88,200 | $39,194 | 44.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 223 | 494 | $60,762 | $32,982 | 54.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 134 | 141 | $48,363 | $20,604 | 42.6% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 25 | 33 | $21,472 | $13,652 | 63.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $26,048 | $11,022 | 42.3% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 16 | 3,604 | $28,800 | $8,620 | 29.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 79 | $13,983 | $7,950 | 56.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 66 | $19,800 | $7,566 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 49 | $15,582 | $7,479 | 48.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 46 | 96 | $11,808 | $5,292 | 44.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 274 | 607 | $9,105 | $4,612 | 50.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 190 | 337 | $11,795 | $3,488 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 48 | $12,096 | $3,354 | 27.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 144 | 202 | $5,050 | $2,986 | 59.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 143 | 201 | $5,025 | $2,896 | 57.6% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 146 | 209 | $5,225 | $2,792 | 53.4% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 145 | 207 | $4,140 | $2,588 | 62.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 14 | 102 | $6,120 | $2,549 | 41.7% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 13 | 28 | $5,208 | $2,331 | 44.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,692 | $2,255 | 48.1% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 67 | 233 | $6,990 | $2,123 | 30.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 179 | 313 | $3,130 | $1,853 | 59.2% |
| 83883 | Nephelometry, test method using light | Office | 2023 | 60 | 126 | $3,150 | $1,680 | 53.3% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 37 | 83 | $2,490 | $1,542 | 61.9% |
About Dr. Bareia Chaudhry, D.O
Dr. Bareia Chaudhry, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2016. The National Provider Identifier (NPI) number assigned to this provider is 1407219728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bareia Chaudhry, D.O has received a total of $1,023 in payments from pharmaceutical and medical device companies, with $616.36 received in 2024. These payments were reported across 42 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,008).
As a Medicare-enrolled provider, Chaudhry has provided services to 4,415 Medicare beneficiaries, totaling 19,811 services with total Medicare billing of $313,106. Data is available for 2 years (2022–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location Stony Brook, NY
- Active Since 04/04/2016
- Last Updated 04/17/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1407219728
Products in Payments
- NINLARO (Drug) $124.99
- IMFINZI (Biological) $92.96
- TECVAYLI (Biological) $83.84
- Stivarga (Drug) $72.19
- VERZENIO (Drug) $48.33
- Kyprolis (Drug) $44.66
- RETEVMO (Drug) $43.78
- Tazverik (Drug) $41.54
- Onivyde (Drug) $34.13
- Enhertu (Drug) $29.98
- SARCLISA (Biological) $28.82
- MONJUVI (Drug) $28.79
- VONJO (Drug) $27.97
- BRUKINSA (Drug) $26.91
- Trodelvy (Drug) $25.78
- PEMAZYRE (Drug) $25.58
- PYLARIFY (Drug) $24.13
- JAKAFI (Drug) $23.05
- KEYTRUDA (Biological) $22.14
- IBRANCE (Drug) $20.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Stony Brook
Noreen Bukhari-Parlakturk, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $26,258
Aadit Shah, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $18,802
Kristine Jang, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $18,437
Mr. Stuart Drew
Student in an Organized Health Care Education/Training Program — Payments: $10,662
Dr. Brian Mccormack, Dds, DDS
Student in an Organized Health Care Education/Training Program — Payments: $9,541
Sonya Marcus, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $8,616